(Thomas Jefferson University) Researchers from the Kimmel Cancer Center at Jefferson and two other institutions have discovered new evidence that suggests the "longevity" protein SIRT1, known for its life-spanning effects in different species, can inhibit the development of a known precursor to prostate cancer, prostatic intraepithelial neoplasia.
intraepithelial neoplasia'Longevity' protein SIRT1 may ward off precursor to prostate can...EurekAlert! - Cancer Wed, 01/12/2011 - 23:00
Tags:
Vaccine Effective Against Vulvar Intraepithelial Neoplasia (CME/...MedPage Today Infectious Disease Wed, 11/04/2009 - 15:00
An experimental vaccine against human papillomavirus (HPV) can produce complete responses in some patients with precancers, Dutch researchers found. Tags:
|
